Streetbeat News

Earnings

DAY

Dayforce (NYSE:DAY) reported Q1 2024 earnings of $0.43 per share, surpassing the $0.42 estimate, marking a 38.71% increase from last year. Sales reached $431.5M, exceeding the $426.048M estimate, a 16.43% year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 11:09 am

CG

Carlyle Group (NASDAQ:CG) reported Q1 2024 adjusted earnings per share (EPS) of $1.01, surpassing the analyst consensus estimate of $0.94 by 7.45%. This represents a 60.32% increase from the $0.63 EPS reported in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 11:09 am

AER

AerCap Holdings has increased its forecast for FY24 adjusted earnings per share (EPS) to approximately $9.20, which is below the estimated $9.95.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 11:08 am

KHC

Kraft Heinz shares are trading lower after the company reported mixed results for the first quarter.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 11:07 am

GRMN

Garmin has confirmed its fiscal year 2024 outlook, maintaining its guidance with expected sales of $5.75 billion and an adjusted EPS of $5.40, aligning closely with analyst estimates of $5.73 billion in sales and an EPS of $5.39.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 11:07 am

CHEF

Chefs' Warehouse projects its FY24 revenue to be between $3.640 billion and $3.785 billion, compared to the estimated $3.72 billion.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 11:07 am

BLCO

Bausch + Lomb has increased its full-year 2024 revenue growth guidance in constant currency terms from 12-14% to 13-15%, with a new revenue target of $4.6B–$4.7B, compared to a consensus estimate of $4.66B.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 11:07 am

CMRX

Chimerix reported Q1 2024 GAAP EPS of $(0.25), missing the $(0.21) estimate by 19.05%, marking a 4.17% increase in losses from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 11:06 am

AVA

Avista Corp has confirmed its earnings per share (EPS) guidance for 2024, projecting a range of $2.36 to $2.56.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 11:06 am

NBIX

Neurocrine Biosciences (NASDAQ:NBIX) reported Q1 earnings of $1.20 per share, surpassing the $1.01 estimate, marking a 335.29% increase from last year. Sales reached $515.30M, exceeding the $511.97M estimate, up 22.57% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 11:06 am